Liver enzyme abnormalities (see Precautions).
Adverse reactions observed in adult patients with primary hyperlipidemia and mixed dyslipidemia: Back pain, constipation, diarrhea, muscle pain, and pain in the extremities. Other reported adverse reactions include arthralgia, headache, influenza, and nasopharyngitis. Laboratory effects have also been reported: increased creatinine phosphokinase, transaminase, alkaline phosphatase, bilirubin, and glucose. Hypersensitivity reactions, including rash, pruritus, and urticaria, have also been reported with pitavastatin use. Other adverse events reported during post-marketing use of Pitavastatin include abdominal pain, indigestion, nausea, weakness, fatigue, malaise, hepatitis, jaundice, fatal and non-fatal liver failure, dizziness, hypoesthesia, insomnia, depression, interstitial lung disease, erectile dysfunction, and muscle spasms. Rarely reported side effects include cognitive impairment (such as memory loss, forgetfulness, memory loss, memory impairment, confusion). Cognitive impairment has been reported with statin use. Very rarely reported side effects include angioedema and immune-mediated necrotizing myopathy (IMNM).
View ADR Reporting Link
Sign Out